title: CsA therapy affects the direct and indirect antigen-presentation pathway in cardiac allograft recipients.
authors.affiliation: Department of Internal Medicine I, University Hospital Rotterdam-Dijkzigt, The Netherlands.
authors.forename: N M
authors.initials: NM
authors.lastname: van Besouw
authors.forename: L M
authors.initials: LM
authors.lastname: Vaessen
authors.forename: A H
authors.initials: AH
authors.lastname: Balk
authors.forename: B
authors.initials: B
authors.lastname: Mochtar
authors.forename: F H
authors.initials: FH
authors.lastname: Claas
authors.forename: W
authors.initials: W
authors.lastname: Weimar
mesh_terms: D000938:Antigen-Presenting Cells / Q000276:immunology*; D002478:Cells, Cultured; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D013154:Spleen / Q000276:immunology; D013745:Tetanus Toxoid / Q000276:immunology; D014019:Tissue Donors; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D013745:Tetanus Toxoid; D016572:Cyclosporine